Enanta Pharma (ENTA) Tops Q1 EPS by 23c

Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of $1.36, $0.23 better than the analyst estimate of $1.13. Revenue for the quarter came in at $48.4 million versus the consensus estimate of $47.05 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
• JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral